The Hidden Engineering Behind Every Pill You’ve Ever Taken
You’ve felt it before.
That moment when a tablet feels just slightly too large.
Too dry. Too rigid. Too… mechanical.
You hesitate.
Take a sip of water.
Try again.
And yet, the question almost never gets asked:
Who decided this should be the size of your medicine?
Because it feels like it must have been designed.
Measured. Optimised. Human-centred.
It wasn’t.
1. The Illusion of Design
Tablet size feels intentional—like it emerged from careful ergonomic study.
But in reality, it is the byproduct of a system:
- Manufacturing constraints
- Material physics
- Regulatory expectations
- Legacy infrastructure
Not human biology.
The modern tablet is not the result of a single decision.
It is the accumulation of thousands of constraints layered over time.
And once you see it, you can’t unsee it:
Tablet size is not designed. It is inherited.
2. Dose: The Starting Point That Misleads Everything
At first glance, tablet size seems obvious:
Bigger dose → bigger tablet
But this is only partially true.
In most tablets:
- The active drug (API) is often a minority of the mass
- The rest is made of excipients:
- Fillers
- Binders
- Disintegrants
- Lubricants
In many cases:
50–90% of the tablet isn’t the drug at all
Why?
Because the drug alone cannot:
- Flow through machinery
- Compress into a stable form
- Break apart reliably in the body
So we build a scaffold around it.
A structural compromise.
3. The Machine Comes First
To understand tablet size, you have to understand the machine.
Modern tablets are made using compression presses—descendants of 19th-century industrial equipment .
These machines rely on:
- Dies (metal cavities that define tablet size and shape)
- Punches (that compress powder into form)
- High-speed repetition (thousands per minute)
And here’s the key:
These machines operate best within standardised size ranges
Typical tooling sizes:
- ~6 mm (small tablets)
- ~8–10 mm (standard oral tablets)
- ~12 mm+ (large-dose drugs)
Changing size isn’t trivial:
- New tooling
- New validation
- New manufacturing setup
So instead, the industry did what industries always do:
It standardised.
Not around humans.
Around machines.
4. The Physics of Compression
Even if you could ignore the machines, physics won’t let you.
A tablet must survive:
- Compression forces
- Packaging
- Transport
- Handling
Without:
- Cracking
- Chipping
- Powdering
At the same time, it must:
- Disintegrate quickly
- Dissolve predictably
- Release drug consistently
This creates a paradox:
Strong enough to survive the world
Weak enough to fall apart inside you
Balancing this requires:
- Minimum thickness
- Specific density
- Structural integrity
Which again… pushes size upward.
5. The Human Constraint (Added Later)
Only after all of this—dose, excipients, machines, physics—does the human enter the equation.
And here’s what we know:
- Comfortable swallow size ≈ 7–10 mm
- Above ~10–12 mm → compliance drops sharply
- Certain groups are heavily affected:
- Elderly
- Children
- Patients with Dysphagia
So what did the industry do?
It adapted—slightly.
- Rounded edges
- Capsule shapes
- Film coatings
But these are surface-level fixes.
Because coatings:
- Add thickness
- Increase size
Which creates a loop:
Make tablets easier to swallow → make them bigger → make them harder to swallow
6. The Cost of Changing Size
If tablet size is suboptimal… why not just change it?
Because in pharma, nothing changes easily.
Altering tablet size means:
- Reformulation
- New stability studies
- New clinical data (in some cases)
- Regulatory reapproval
Agencies like the Food and Drug Administration prioritise:
- Consistency
- Predictability
- Proven formats
And tablets—at their current sizes—are deeply validated.
So the system optimises for:
What is already approved
Not what is optimal.
7. The Hidden Trade-Off
When you zoom out, the reality becomes stark:
Tablet size is the result of optimising for:
- Manufacturing efficiency
- Mechanical reliability
- Regulatory simplicity
At the expense of:
- Patient experience
- Biological variability
- Absorption optimisation
It is a system-level compromise.
One that patients feel—literally—every day.
8. The Bigger Problem: Fixed Physical Dosing
Tablet size exposes a deeper issue:
We tie dose to physical form
Need a higher dose?
→ Make a bigger tablet
But humans aren’t standardised:
- Weight
- Metabolism
- Absorption
- Disease state
Yet we deliver medicine in:
fixed, rigid, physical units
It’s elegant for manufacturing.
It’s flawed for biology.
9. The Ibumix Perspective: Designing From First Principles
If you were starting today—without history, without machinery, without regulatory inertia—you would not design medicine like this.
You wouldn’t:
- Bind dose to size
- Force patients to swallow solids
- Accept dissolution as a bottleneck
You would design for:
- Absorption, not compression
- Precision, not standardisation
- Patients, not production lines
And that leads to a different question entirely:
Not “How big should a tablet be?”
But “Why is there a tablet at all?”
10. The End of the Assumption
The tablet feels inevitable.
It isn’t.
It is the product of:
- Industrial-era machinery
- Legacy standardisation
- Regulatory reinforcement
A format that solved the problems of the past—
and now constrains the possibilities of the future.
The size of a tablet was never truly decided.
It simply… settled.